百奥赛图-B(02315.HK)A股发行注册获中证监批准
BiocytogenBiocytogen(HK:02315) Ge Long Hui·2025-10-16 12:12

Core Viewpoint - The company, Baiaosaitu-B (02315.HK), has received approval from the China Securities Regulatory Commission (CSRC) for its A-share issuance registration application, effective October 15, 2025 [1] Group 1 - The approval marks a significant milestone for the company in its efforts to expand its capital base through A-share issuance [1] - The registration approval is expected to enhance the company's financial flexibility and support its growth strategies [1]